Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial

Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial

Bibliographic Details
Main Authors: Haude, Michael, Ince, Hüseyin, Abizaid, Alexandre, Toelg, Ralph, Lemos, Pedro Alves, von Birgelen, Clemens, Christiansen, Evald Høj, Wijns, William, Neumann, Franz-Josef, Kaiser, Christoph, Eeckhout, Eric, Lim, Soo Teik, Escaned, Javier, Onuma, Yoshinobu, Garcia-Garcia, Hector M., Waksman, Ron
Format: Online
Language:English
Published: Oxford University Press 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037291/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037291/

Similar Items